Cannabis in Belgium

In 2024, the Belgian cannabis market continues to grow, with the CBD category leading the way. CBD flower is the most popular product, followed by CBD oil. The medical cannabis market is also expanding, despite strict regulations, although the availability of products remains limited. While adult-use cannabis remains illegal in Belgium, legalisation is not anticipated in the near future due to a complex political environment, which in turn contributes to the growth of the illicit market.

Euromonitor International's Cannabis in Belgium market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2029 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.